Background: Obesity is a complex, multifactorial disorder influenced by the interaction of genetic, epigenetic, and environmental factors. Obesity increases the risk of contracting many chronic diseases or metabolic syndrome. Researchers have established several mammalian models of obesity to study its underlying mechanism. However, a lower vertebrate model for conveniently performing drug screening against obesity remains elusive. The specific aim of this study was to create a zebrafish obesity model by over expressing the insulin signaling hub of the Akt1 gene.
Introduction
Obesity has become a worldwide health problem in recent decades. According to the International Obesity Task Force (IOTF), the worldwide overweight population now exceeds 1.7 billion. The potential risks of obesity or metabolic syndrome will affect human health and life quality. In addition, chronic diseases like diabetes, hypertension, hyperlipidemia, cardiovascular disease, and cancer are directly associated with obesity [1, 2, 3, 4, 5] . However, the mechanism for inducing obesity is unclear. Evidence collected from recent studies indicates that obesity involves complex physiological disorders and is influenced by the interaction of genetic, epigenetic, and environmental factors [6, 7, 8] . To simplify the complexity, current methods of probing adipogenesis, obesity-related chronic diseases and metabolic syndrome largely rely on conventional in vitro cell culture and in vivo animal models. Cell culture can manipulate culture conditions to evaluate the biological effects of exogenous drug or hormone treatment on adipocyte differentiation. For example, 3T3-L1 fibroblast cells [9] and embryonic stem (ES) cells [10, 11] can be efficiently induced to adipocyte cells when retinoic acid (RA) and adipogenic hormones are administrated in vitro. However, since obesity is the dysregulated outcome of multiple physiological processes on several target organs, it is insufficient to explore the physiological or cellular mechanisms of human obesity using an in vitro approach. Therefore, researchers have successfully developed several animal models in nematodes [12, 13] , flies [14, 15] and rodents [16, 17] to probe adipogenesis and the disease mechanism of human obesity in vivo.
The conventional murine model provides a gold standard for human obesity research. For example, mice deficient in leptin (ob/ob) [18, 19, 20, 21] , leptin receptor (db/db) [22, 23] or Ankrd26 [16] genes spontaneously display an obese phenotype because their appetite is out of control, leading to extra food intake. It is also possible to explore novel and evolutionary conserved genes on controlling lipid metabolic pathway and adipocyte development by performing large-scale forward and reverse genetic screening in worms and flies [24, 25] . However, because of the distinct anatomy of higher vertebrates, it is not possible to measure some physiological parameters, such as blood glucose levels and insulin resistance, in worms and flies. Therefore, it is necessary to develop a lower vertebrate obesity model to overcome this bottleneck and accelerate research.
The zebrafish model has recently emerged as a new and attractive animal model for human disease and obesity [26, 27, 28] . Several lines of evidence support the idea that zebrafish allow the study of adpiogenesis and modeling of human obesity. First, the nile red staining method of detecting lipids in living fish has been established and can be used to follow the adipogenesis process in real time [29] . Second, the cellular anatomy of zebrafish adipocytes is similar to mammalian white adipocytes, and most of the marker genes in adiopogenesis or lipogenesis pathway have been characterized [29] . Third, the method of measuring blood glucose in zebrafish has been established [30, 31] , making it possible to use zebrafish as a new powerful animal model for probing human obesity. Fourth, transcriptomic studies indicate a similarity in the gene expressional profiling of diet-induced obesity between fish and mammals [28] . Finally, Song and Cone demonstrated that the overexpression of endogenous melanocortin antagonist agoutirelated protein (AgRP) in transgenic zebrafish can enhance appetite and induce obese phenotype in live zebrafish [32] . These results demonstrate that the key components of the adipostat are conserved between fish and mammals, highlighting fish as an alternative and inexpensive animal model for human obesity.
Akt (also known as protein kinase B, PKB) is a serine/threonine protein kinase that regulates cell survival, cell growth, cell cycle, cell proliferation, cell metabolism, cell migration/invasion, angiogenesis, and functions an essential hub gene to crosstalk with numerous signaling pathways [33, 34, 35] . The phosphatidylinositol 3-kinase (PI3-K)/Akt signaling pathway also plays a key role in regulating adipocyte differentiation and lipogenesis in vitro [36, 37, 38] . The enforced expression of the constitutively active form of Akt1 (myrAkt1) in 3T3-L1 pre-adipose cells can promote spontaneous adipose differentiation [39] . In contrast, mice lacking Akt1 has reduced body size and impeded subcutaneous adipogenesis [40, 41] . These results underline the pivotal role of Akt1 in adipogenesis regulation and organism development. Although the Akt1 functions on adipogenesis and fat homeostasis have been extensively studied, few studies have investigated whether they also play a role in lower vertebrate of fish.In our lab, wehave performed a large-scale screen to evaluate the oncogenic transformation potential of human genes in zebrafish. To our surprise, we identified that a transgenic line of Tg(krt4:Hsa.myrAkt1) cy18 displays an obese phenotype. This study describes the phenotype of Tg(krt4:Hsa.myrAkt1) cy18 on morphological and molecular levels. Results reveal that the Akt1 pathway plays a key role in adipogenesis in vivo. Thus, this study provides a new lower vertebrate model to study human obesity.
Results
Generation of Tg(krt4:Hsa.myrAkt1) cy18 Zebrafish Line
We performed a large-scale screen to identify the oncogenic potential of human genes in zebrafish skin. Human genes were placed under the control of zebrafish skin-specific keratin4 (krt4) promoter and injected expressional vectors into one-cell stage zebrafish embryos. The injected embryos were raised to adult and the stable transgenic fish were screened by outcrossing with wild-types. To facilitate fluorescence-based phenotypic screening and enhance the germ-line transmission rate, we used Tol2Kit vector [42] that contains the cmcl2-EGFP-pA mini-cassette at the 3'end and the Tol2 transposable elements flanking the whole transgene cassette at both ends (Fig. 1A) . The zebrafish endogenous 2.2 kb krt4 promoter is able to drive transgene expression in the superficial skin layer of zebrafish [43] . The myrAkt1 is depleted of the N-terminal PH domain and fused with the myristylation signal, bypassing the need for activation of phosphoinositides 3,4,5-trisphosphate (PIP3) and PIP2 generated by PI3K (Fig. 1A) . Therefore, the myrAkt1 cannot be inhibited by PTEN, a tumor suppressor that acts as a negative regulator of the PI3K pathway, and will constitutively activate the Akt1 downstream signals. The p3E-IRES-EGFP-pA encodes a cytoplasmic-targeted EGFP, followed by a SV40 late polyA signal sequence [42] , and is a reporter for monitoring the myrAkt1 expression in epidermis.
To generate the transgenic zebrafish, the expressional construct was co-injected with in vitro transcribed Tol2 transposase mRNA into the one-cell stage of wild type embryos. The injected embryos were examined for the expected mosaic expression of green fluorescence protein in the heart at 28-35 hour post-fertilization (hpf). With the help of the Tol2 transposon system, we identified 15 independent lines out of 31 putative founders (germ-line transmission rate = 48%). However, IRES did not activate very well because many transgenic lines with the green heart phenotype displayed very weak EGFP expression in their skin, or none at all. Therefore, we used the cmlc2-EGFP-pA mini-cassette to screen putative founders. Data from genotyping results confirmed the fluorescent heart is a reliable marker of stable transgenic lines because embryos with a green heart are 100% positive for krt4-myrAkt1transgene (data not shown). Next, we performed Western blot and immunostaining to determine whether the exogenous human myrAkt1 gene is overexpressed in a skin-specific manner. Protein lysates extracted from the pooled tail fins were analyzed by SDS-PAGE and immunoblotted by total Akt1/2/3 or p-Akt1 (S473) antibodies. Results show the Akt1/2/3 antibody can recognize endogenous Akt proteins in both wild type (WT) and Tg(krt4:Hsa.myrAkt1) cy18 . However, only transgenics were positive for exogenous myrAkt1 proteins (42 kDa), which showed smaller size than the endogenous one (Fig. 1B) . In addition, transgenic but not WT displayed overphosphorylation at position S473 when probed with p-Akt1 antibody (Fig. 1B) . Whole-mount immunostaining also confirmed the expression of myrAkt1 (membranebound signals) in Tg(krt4:Hsa.myrAkt1) cy18 (Figs. 1E and 1F) but absent in WT skin (Figs. 1C and 1D ). Collectively, these results indicate the generation of Tg(krt4:Hsa.myrAkt1) cy18 to target human myrAkt1 expression in the epidermal layer.
Overexpression of myrAkt1 is Sufficient to Induce the Hypertrophic and Hyperplastic Growth of Skin in Zebrafish Larvae
The overexpression of Akt in a murine model can induce skin hyperplasia and promote cancer malignancy [44, 45] . This observation suggests that the overexpression of myrAkt1 can induce cancer formation in zebrafish skin. Tg(krt4:Hsa.myrAkt1) cy18 larvae exhibited a rough organized skin phenotype from approximately 60 hpf onwards (data not shown). By 72 hpf, the scaly skin phenotype was more pronounced on the head (Fig. 2B) , pericardial cavity (Fig. 2D ), yolk sac (Fig. 2D) , and tail fin (Fig. 2F ) surface in Tg(krt4:Hsa.myrAkt1) cy18 . By 120 hpf, the skin of Tg(krt4:Hsa.-myrAkt1)
cy18 larvae was more bulged and wrinkled than 72 hpf. This striking skin phenotype was clearly apparent even under a low power magnification (Figs. 2H and 2J). Whether this scaly skin phenotype in myrAkt1-overexpressing larvae was caused by skin hypertrophy or hyperplasia is an interesting topic. We answered this question by performing skin section and skin cell counting on embryos aged at 120 hpf. Akt is the intermediate hub on the growth factor and insulin pathway, and plays an essential role in controlling processes such as cell size, volume, and survival by activating its downstream targets through phosphorylation [46, 47] . The observation of hypertrophic and hyperplastic transformation in Tg(krt4:Hsa.myrAkt1) cy18 larvae skin is intriguing, and leads us to ask whether this striking phenotype transformation is caused by exogenous human myrAkt1 activity. Following this rationale, it should be able to detect the over-phosphorylation of endogenous Akt downstream targets and restore the skin phenotype when Akt downstream signaling is blocked. To validate this hypothesis, we first checked the phosphorylation status of three well known Akt downstream targets of glycogen synthase kinase 3 alpha/beta (GSK3a/b), mammalian target of rapamycin (mTOR) and 70-kDa S6 protein kinase (70S6K) using phosphospecific antibodies against each proteins. Western blot supports this speculation because the immunoreactive signals for either pGSK3a/b, p-mTOR or p-70S6K are much stronger in Tg(krt4:Hsa.myrAkt1) cy18 than those in WT (Fig. 3A) . Because the skin-specific overexpression of human myrAkt1 is not lethal to transgenics, it is possible to observe the late phenotype in Tg(krt4:Hsa.myrAkt1) cy18 . When Tg(krt4:Hsa.myrAkt1) cy18 reach sexual maturation, the most noticeable phenotypic characteristic is their superior growth rate. We measured the body length and body weight of both genders at one month intervals from 3 to 5 months, and found the body weight but not the body length of both genders display significant increase in Tg(krt4:Hsa.myrAkt1) cy18 (Table 1) . Conditional factor, which compares weight and length, defines the fishes mass index. This resembles human body mass index (BMI), and is a good index for measuring obesity in fish. The Tg(krt4:Hsa.myrAkt1) cy18 showed a significant increase of conditional factors in both male (37-89% increased, Fig. 4A ) and female (84-311% increased, Fig. 4B ) compared to WT siblings.
In addition to body growth rate, a striking example of phenotypic transformation is the appearance of ectopic bulges in the head, subcutaneous epidermis, and tail fins for founders or stable transgenics carrying krt4:myrAkt1 transgene at the adult stage (Fig. 4D) . The morphology and white color of the bulges suggests that this ectopic structure in Tg(krt4:Hsa.myrAkt1) cy18 is caused by abnormal fat accumulation. We tested this speculation by Oil Red O staining in the whole animal for WT ( Fig. 4C ), F0 founder ( Fig. 4D) , and F1 Tg(krt4:Hsa.myrAkt1) cy18 (Figs. 4E and 4F). Results reveal heavily red stained lipid areas in the protruding bulges on the face and tail regions of trangenics. When myrAkt1 transgenes are somatically integrated, F0 founders display ectopic fat accumulation (Fig. 4D) . However, when myrAkt1 transgenes are germ-line integrated, stable transgenics display more evenly distributed fat accumulation over the entire fish at 3 months (Fig. 4E ). In 12 month-old fish, the obese Tg(krt4:Hsa.myrAkt1) cy18 showed more pronounced lipid accumulation along the entire body (especially in the tail fin and visceral regions) and an up-bent body shape (Fig. 4F) . The lipids consist primarily of triglycerides and cholesterol. Measurements of the whole body total triglycerides (TG) and total cholesterol (TC) content in Tg(krt4:Hsa.myrAkt1) cy18 at 5 months showed a 64% to 65% increase in total triglyceride content for male and female Tg(krt4:Hsa.myrAkt1) cy18 , respectively, compared to WT siblings (Table 1) . However, the total cholesterol content, show no significant difference between WT and Tg(krt4:Hsa.myrAkt1) cy18 for both genders (Table 1) . These results indicate that the lipid accumulation in obese Tg(krt4:Hsa.myrAkt1) cy18 primarily consists of excess triglycerides, and not cholesterol accumulation. Next, we would like to characterize the initiation time and the initiation site for Tg(krt4:Hsa.myrAkt1) cy18 to display obese phenotype. We performed nile red vital staining on living larvae/juvenile at 7 day intervals to observe the lipid deposition over time. From 7 cy18 is detectable at the juvenile to adult transitory stage. Next, we examined the histological observation of adipocyte distribution pattern between WT and transgenics. An entire adult fish aged 5 to 6 months old was sagittally sectioned to determine the distribution of adipose tissues in WT and Tg(krt4:Hsa.myrAkt1) cy18 (Fig. 5A ). In WT, adipose tissues were rarely detected in the compartment between the scale and muscle of the dorsal body (Fig. 5B) , but restricted to compartments surrounding the visceral organs (Fig. 5D) and bone (Fig. 5H) . However, in obese transformed Tg(krt4:Hsa.myrAkt1) cy18 , some ectopic adipocytes were detected in the compartment between the scale and muscle of the dorsal body (Fig. 5C ) and the gill arch (Fig. 5G ). In addition, Masson's trichrome staining revealed bone cells in the vertebrate column and skeletal muscle cells infiltrated and replaced by excess adipocytes in Tg(krt4:Hsa.myrAkt1) cy18 (Fig. 5I ).
The obese transformation and abnormal fat accumulation in Tg(krt4:Hsa.myrAkt1) cy18 might be caused by adipocyte hypertrophy or hyperplasia. We addressed this question by quantifying adipocyte cell and size in the visceral region. Statistical analysis reveals the adipocyte number (Fig. 5K ), but not size (Fig. 5J) , in the visceral region was higher in Tg(krt4:Hsa.myrAkt1) cy18 than in WT. Adipocyte size distribution histogram shows that the obese Tg(krt4:Hsa.myrAkt1) cy18 is primarily caused by an increase of small adipocytes (Fig. 5L) . Collectively, these results confirm that the extreme obese phenotype detected in Tg(krt4:Hsa.myrAkt1) cy18 is primarily caused by adipocyte hyperplasia rather than hypertrophy.
The Obese Transformation in Adult Tg(krt4:Hsa.myrAkt1) cy18 Is Contributed by the Ectopic Expression of myrAkt1
The intriguing obese phenotype in Tg(krt4:Hsa.myrAkt1) cy18 suggests that using krt4 promoter to force express human myrAkt1 gene in the superficial skin layer can boost unexpected obese transformation at the adult stage. Kawakami and colleagues described the random integration nature of Tol2 transposon system when applied in zebrafish [48, 49] . Therefore, this study hypothesizes that (1) the krt4:myrAkt1 transgene might integrate into a specific gene to interfere with its expression and function. (2) the krt4:myrAkt1 transgene might trap neighboring enhancer and misexpress at the adipocyte lineage. This first possibility was tested by exploring the chromosomal integration site in Tg(krt4:Hsa.myrAkt1) cy18 . We extracted genomic DNA, digested it with restriction enzyme, ligated it with adapter, and performed long range PCR to idenify the putative DNA sequences flanking the integration site (Fig. S1) . Results show that the krt4:myrAkt1 transgene was reversely inserted into the intergenic region between two unannotated genes of ENSDART00000136020 and EN-SDART00000133739, which were located in a guanine nucleotide-binding protein G(q) subunit alpha-like gene cluster on chromosome 22 (Figs. 6A and S1) . Therefore, the obese transformation in Tg(krt4:Hsa.myrAkt1) cy18 is probably not caused by insertional mutagenesis. Next, we performed real-time RT-PCR to evaluate the relative expression levels of human myrAkt1 gene in multiple tissues. In addition to its original expression territory in skin (62 fold upregulation), myrAkt1 transcripts were ectopically detected in liver (3 fold upregulation), muscle (7 fold upregulation), and bone (2 fold upregulation) of Tg(krt4:Hsa.myrAkt1) cy18 unlike WT siblings (Fig. 6B) . Immunohistochemistry on paraffin sections with Akt downstream target antibody also showed stronger pmTOR-immunoreactive signals in the internal adipose tissues of Tg(krt4:Hsa.myrAkt1) cy18 (Fig. 6D) than WT (Fig. 6C ). To test whether the ectopic expression of myrAkt1 transgene is influenced by the enhancer activity of the neighbor genes located adjacent to the transgene integration site, total RNA were extracted from multiple tissues of transgenic fish and performed real-time RT-PCR to compare the relative mRNA expression level of ENSDART00000133739 and ENSDART00000136020 genes. Results showed the relative expression level of EN-SDART00000133739 is very low (compared to b-actin2) and majorly expressed in the gill tissue (Table S2 ). The relative abundance of ENSDART00000133739 transcripts is distinct from the myrAkt1 transcripts detected in Tg(krt4:Hsa.myrAkt1) cy18 . For ENSDART00000136020, it behaviors as a pseudogene since realtime RT-PCR assay failed to detect any gene transcript in either whole fish, whole embryos or adult tissues (Table S2 ). In addition, no expressed sequence tags (EST) corresponding to EN-SDART00000136020 can be detected in Zebrafish EST database. Therefore, the obese transformation in Tg(krt4:Hsa.myrAkt1) cy18 is probably not contributed by insertional mutagenesis or enhancer trapping of the adjacent neighbor genes. In addition, the obese transformation phenotype is unique to Tg(krt4:Hsa.myrAkt1) cy18 but not appear in other independent lines carrying the same injecting plasmid. Taken together, these results prove that the obese phenotype in Tg(krt4:Hsa.myrAkt1) cy18 is caused by the ectopic expression of the myrAkt1 gene which might be influenced by other long distance enhancer activity.
Myogenic, Skeletogenic, Adipogenic, Adipocytokine, and Inflammation-related Genes are Deregulated in Tg(krt4:Hsa.myrAkt1) cy18
The obese transformation of dorsal muscle tissues and tail bone tissues suggest that the normal myogenic and skeletogenic program might be interfered in Tg(krt4:Hsa.myrAkt1) cy18 . To clarify this speculation, we examined the mRNA expression profile of key genes on regulating myogenesis and skeletogenesis using real-time RT-PCR. Myogenic factor 5 (myf5), myogenic factor 6 (myf6), myogenin (myog), myogenic differentiation 1 (myod1), and skeletal muscle myosin light polypeptide 2 (mylz2) are critical myogenic regulatory factors and structural proteins controlling myogenesis [50, 51, 52, 53, 54, 55] . Results show that most gene transcripts (excluded myog) were downregulated in Tg(krt4:Hsa.myrAkt1) cy18 (Fig. 7A ). For skeletogenesis, runt-related transcription factor 2 (runx2) is a master osteoblast-specific transcription factor that plays an essential role in osteoblast differentiation and skeletal morphogenesis in mammals [56, 57] . Matrix gla protein (mgp) and collagen type II, alpha-1a (col2a1a) are key players in the organization of cartilage tissues [58, 59, 60] . Real-time RT-PCR revealed a significant downregulation of runx2a and col2a1a in Tg(krt4:Hsa.myrAkt1) cy18 (Fig. 7A ). In addition, the genes related to adipogenesis and lipogenesis were strongly upregulated in Tg(krt4:Hsa.myrAkt1)
cy18 . The adipogenesis analysis in this study focused on two master transcription factors of peroxisome proliferator-activated receptor gamma (pparg) and CCAAT/enhancer binding protein a (cebpa) because the interplay between pparg and cebpa is a crucial in activating adipocyte differentiation and adipogenesis-related program [36, 37, 38] . To test fatty acid transport, triglyceride, cholesterol synthesis, and lipogenesis, we monitored the expression of fatty acid-binding proteins (fabp11a and fabp11b) [29] , sterol regulatory element binding transcription factor 1 (srebf1) and srebf2 [61] , lipoprotein lipase (lpl, for lipoprotein metabolism) and stearoyl-CoA desaturase (scd, for unsaturated fatty acid biosynthesis), respectively. As expected, most gene transcripts (except srebf2) showed 2-110,000 fold upregulation in Tg(krt4:Hsa.myrAkt1) cy18 (Fig. 7B) . In summary, the gene expression profile assayed by real-time RT-PCR agreed with the findings collected from morphological and biochemical analysis in the obese transformed Tg(krt4:Hsa.myrAkt1) cy18 . The global upregulation of gene transcripts in adipogenic and lipogenic program is not surprising because they are the consequences of obesity. To identify unknown factors controlling the obese transformation, we performed oligonucleotide microarray analysis to compare gene transcriptome between WT and Tg(krt4:Hsa.myrAkt1) cy18 at five months. Compared to WT, 68 and 179 genes were either significantly up or downregulated in Tg(krt4:Hsa.myrAkt1) cy18 . Pathway analysis based on gene ontology identified the inflammatory response pathway (like mmp2 gene) as a major hub among all upregulated genes (Fig. S2) . In mammals, obesity is directly associated with chronic inflammatory response [62] . The adipose tissue in obese animals can interact with neighboring neutrophils or macrophages by releasing adipocytokine or macrophage-derived factors [63] . This microarray data inspired us to test whether the inflammatory response was triggered in the obese transformed zebrafish. We initially validated this hypothesis by examining the expression of adiponectin (adipoql and adipoql2), adiponectin receptors (adipor1a, adipor1b and adipor2) [64] , leptin receptor (lepr), and lipin1. Systematic analysis shows that the majority of the adipocytokines (except adipor2) are upregulated in Tg(krt4:Hsa.myrAkt1) cy18 (Fig. 7C) . Next, we examined the expression level of inflammatory genes released from macrophages. Again, most of the macrophage-derived factors such as tnfa, il1b, mmp2, and mmp9 are strongly upregulated in Tg(krt4:Hsa.myrAkt1) cy18 (Fig. 7C) . To confirm the inflammatory response at cellular level, we crossed Tg(krt4:Hsa.myrAkt1) cy18 with Tg(mpx:GFP) i113 to produce a double transgenic line of Tg(krt4:Hsa.myrAkt1) cy18 ; Tg(mpx:GFP) i113 to highlight the green neutrophils in the obese background. We observed the relative number of neutrophils under the fluorescent microcope and found the neutrophils in normal condition were widely and evenly distributed in the whole fish (Fig. 7D) . However, the tail region of obese transformed Tg(krt4:Hsa.myrAkt1) cy18 exhibited extremely strong fluorescent signals because of the unusually high level of neutrophil aggregation (Fig. 7E, highlighted with a red dotted  circle) . Taken together, these results clearly show that the ectopic activation of human myrAkt1 in zebrafish mesenchymal derived tissues may activate adipogenesis at the expense of other mesenchymal cells. This ultimately leads to obese transformation in zebrafish.
Tg(krt4:Hsa.myrAkt1) cy18 Displays Obese-Related Disease Phenotype
The lipoma-like obese transformation in Tg(krt4:Hsa.myrAkt1) cy18 suggests that the normal physiology has been deregulated and is replaced with a metabolic syndrome-like phenotype. A swimming behavior assay revealed that the obese fish were less active than WT (Figs. 8A and 8B ). This reduction of swimming ability might be caused by the loss of muscle, which was replaced by ectopic fat (Fig. 5I) . In addition, the survival rate of obese fish was significantly lower than that of WT (Fig. 8C) , and most obese were not able to survive longer than two years (data not shown).
To test the blood glucose intolerance, we compared the fasting, feeding, and post-feeding blood glucose levels of adult WT and Tg(krt4:Hsa.myrAkt1) cy18 . This assay is routinely applied in rodents to test whether the experimental animal displays insulin resistance, as indicated by the modulation of blood glucose levels. To model the fasting condition, fish were not fed for 24 hr before blood sampling. To model the feeding condition, fish were initially immersed in 5% glucose solution for 24 h to raise the blood glucose level. In both cases, blood was sampled by decapitation to measure glucose levels. In the fasting condition, the blood glucose level of WT (73615 mg/dl) and transgenics (64634 mg/dl) was tightly regulated at less than 100 mg/dl (Fig. 8D ). After challenging with 5% glucose for 24 hr, the blood glucose in both WT (3176138 mg/dl) or transgenics (3156150 mg/dl) was greatly elevated, exceeding the critical level of hyperglycaemia (200 mg/dl) [30] . However, compared to WT (77611 mg/dl), Tg(krt4:Hsa.myrAkt1) cy18 fish exhibited impaired glucose clearance (115629 mg/dl) during the recovery period (Fig. 8D) . This result indicates that changes in adiposity can reduce glucose tolerance in Tg(krt4:Hsa.myrAkt1) cy18 .
Discussion

Akt1 Functions as a Powerful Cell/Organ Size Controller
The over expression of the constitutively active form of human myrAkt1 can phosphorylate endogenous downstream targets like mTOR and 70S6K. This in turn boosts the hyperplastic and hypertrophic growth of zebrafish skin cells. The morpholino-based loss-of-function approach provides direct evidence supporting the skin hyperplasia/hypertrophy in Tg(krt4:Hsa.myrAkt1) cy18 mediated by Akt1-mTOR-70S6K path-way activation. These findings agree well with previous studies showing that Akt signaling is essential for controlling cell and organ size in mammalian heart [65, 66, 67] , skeletal muscle [68] , and whole organism [40, 41] . Therefore, these findings confirm that Akt1 plays an evolutionary conserved role in controlling cell and organ size, from fly to mammal. In contrast, careful examination of skin morphology at histological and cellular levels failed to reveal any sign of cancer transformation in Tg(krt4:Hsa.myrAkt1) cy18 skin. This observation is inconsistent with previous observations in mice because the single activation of myrAkt1 induces spontaneous skin cancer formation [45] . The exact reason for this species-specific difference of Akt1 function on skin is currently unknown, but might be related to the basic physiological difference between endothermic and ectothermic vertebrates. In endothermic vertebrates, only the stem cells located in the basal layer have mitotic potential [69] . In ectothermic vertebrates, cells in all epidermal cell layers are capable of undergoing mitotic division [70] . Recent research demonstrates that skin-specific co-activated Hh signaling with myrAkt1 in zebrafish skin can induce oncogenic transformation in many tissues, but not in skin itself [71] . In the same manner, this study finds no skin transformation in single transgenic carrying myrAkt1. This suggests that fish skin might be more resistant to oncogenic transformation compared to their mammalian counterparts. Future research involving a transgenic zebrafish line carrying multiple oncogenic genes might be able to overcome this oncogenic transformation threshold.
Tg(krt4:Hsa.myrAkt1) cy18 Provides a New Lower Vertebrate Obesity Model
Adipocytes originate from meschymal stem cells, and their differentiation is tightly controlled by pparg and cebpa transcriptional factors. The positive regulatory loop between pparg and cebpa can activate the terminal differentiation cascade of adipogenesis. Although many in vitro studies have indicated that the Akt function is upstream of pparg and cebpa in modulating adipogenesis [36, 37, 38, 39, 40, 41] , the in vivo evidence to support Akt function on adipogenesis remains limited. Only a few reports have shown that mice deficient in both Akt1/Akt2 will display the obese phenotype [40] . This study is the first to use the gain-of-function approach to provide direct evidence that Akt1 function is required to activate [32] . This study develops a new generation of obese fish model of Tg(krt4:Hsa.-myrAkt1) cy18 , using myrAkt1 to directly activate adipogenesis and enhance the hyperplastic growth of adipocytes. Compared to Tg(b-actin:AgRP), the Tg(krt4:Hsa.myrAkt1) cy18 obesity model contains several interesting phenotypes: (1)The over expression of AgRP and myrAkt1 has a significant effect on adipocyte differentiation. Both hypertropic and hyperplastic growth of adipocyte appear in Tg(b-actin:AgRP), while only the hyperplastic growth of adipocyte appears in Tg(krt4:Hsa.myrAkt1) cy18 . (2) Tg(krt4:Hsa.myrAkt1) cy18 exhibits abnormal lipoma-like fat tissue accumulation in dorsal muscle tissues, gill arches, and tail bone tissues, whereas Tg(b-actin:AgRP) displays a normal adipocyte distribution. (3) The Tg(krt4:Hsa.myrAkt1) cy18 displays blood glucose intolerance, but Tg(b-actin:AgRP) does not. Therefore, the lipoma-like Tg(krt4:Hsa.myrAkt1) cy18 reported in this study serves as a good disease model for modeling obesity-induced chronic disease according to the following phenotypic signatures: a great increase in weight gain (Figs. 4A and 4B ) and whole body triglyceride content (Table 1) , a symptom of muscle contraction weakness (Fig. 8B ) and osteoporosis by adipocyte infiltration (Fig. 5J) , high neutrophil infiltration (Fig. 6E) , glucose intolerance (Fig. 7) , and short life span (Fig. 8C) . Therefore, Tg(krt4:Hsa.myrAkt1) cy18 provides a unique and valuable lower vertebrate model to study the mechanism of obesity-induced metabolic deregulation for the first time.
Lipoma Formation is Associated with the Unbalance of Akt Signaling
Lipoma is a kind of benign, soft tissue tumor characterized by abnormal cell proliferation in adipose tissue. Although cytogenetic research shows that human lipoma formation is associated with the translocations and fusion of HMGA2-NFIB [72] , HMGIC-LPP [73] , and C11orf95-MKL2 [74] , there is little monogenic evidence of lipoma formation. By deleting the PTEN gene in the skeletal lineage, Hsieh and colleagues unexpectedly discovered abnormal lipoma formation in bone and muscle tissues [75] . PTEN is a tumor suppressor gene frequently detected in sporadic human cancers. PTEN negatively regulates the Akt survival signaling by dephosphorylating PIP3 [76] . Once PTEN activity is compromised, the Akt signal is no longer suppressed and the activated Akt can subsequently activate many downstream targets on mediating cell growth, cell survival, and metabolism [77] . The myrAkt1 gainof-function transgenic fish in this study also display abnormal lipoma transformation in skin, bone, and muscle, agreeing well with the findings reported in PTEN-deficient mice. The lipoma transformation phenotype detected in Tg(krt4:Hsa.myrAkt1) cy18 is closely related to superficial subcutaneous lipoma (appearing in skin), chondroidlipoma (appearing in bone) and well-differentiated liposarcoma (appearing in muscle), which have been clinically reported in human patients. Therefore, the proposed obese zebrafish model confirms that PTEN-Akt signaling plays an evolutionary conserved role in controlling adipose tissue development. The obese transformed zebrafish model is also a valuable tool for studying obese-related chronic disease at the organism level. 
Materials and Methods
Animals
The AB strain zebrafish (Danio rerio) were obtained from ZIRC (http://zebrafish.org/zirc/home/guide.php), and kept in the stock of Chung Yuan Christian University. Zebrafish were raised in local tap water at 28.060.5uC under a constant 14 hour light/10 hour dark cycle. After spawning, Zebrafish embryos were collected in 10 cm Petri dishes containing 20 mL fish water and raised at 28.060.5uC. To prevent disease from attacking zebrafish embryo, a few drops methylene blue were added to the fish water. At 5 to 7 dpf, larvae were transferred to 10 L tanks containing 8 L of fish water and fed with live Paramecium. After 14 dpf, larvae were fed two times daily with live artemia (OSI, USA) until they reached adulthood.
Plasmid Construction
We used Tol2 kit [42] to rapidly assemble expression vectors by three-fragment gateway recombination cloning. To create the 59 entry clone, we amplified 2.2 kb krt4 promoter from genomic DNA by PCR with forward primer (59-GGGGACAACTTTG-TATAGAAAAGTTGCCTTCCCTTCTACTTTTGACGTCC -39) and reverse primer (59-GGGGACTGCTTTTTTGTA-CAAACTTGCCGGATC-CTGTGTCTTTGAGTTGC-39). The attB4 and attB1r sites were added at the 59end of the primers and highlighted by underlines. The PCR products were then cloned into pDONRP4-P1R (Invitrogen) by BP reaction to obtain p5E-krt4. The resulting p5E-krt4 vector contains 2.2 kb upstream regulatory sequences of krt4 gene that is sufficient to drive target gene specifically express in the superficial skin cells [71] . To create the middle entry clone, we amplified human myrAkt1cDNA from plasmid myrAkt delta4-129 (Addgene 10841) using forward primer (59-GGGGACAAGTTTGTACAAAAAAGCAGGC-TATGGGGAGTAGCAAGAGCAAGC-39) and reverse primer (59-GGGGACCACT-TTGTACAAGAAAGCTGGGTT-CAGGCCGTGCCGCTGGCCGAG-39). The attB1 and attB2 sites were added at the 59end of primers and highlighted by underlines. The PCR products were cloned into pDONR221 (Invitrogen) to generate pME-myrAkt1. The resulting pMEmyrAkt1 vector contains the constitutively active form of human Akt1 gene with the 14 aa src myristoylation signal fused to the N terminus of human Akt1 delta 4-129. Finally, p5E-krt4, pMEmyrAkt1, and p3E-IRES-EGFPpA [42] were joined with pDestTol2CG2 [42] by LR reaction to create the expression vector of pDestTol2CG2-krt4-myrAkt1-IRES-EGFP-pA.
Microinjection and Identification of Transgenic Zebrafish
Transposase RNA was synthesized in vitro using pCStransposase plasmid (kindly provided by Dr. Koichi Kawakami) as a template. DNA was linearized with NotI at 37uC overnight and cleaned using DNA Clean/Extraction Kit (GeneMark Inc., Taiwan). Capped mRNA was synthesized by mMESSAGE mMachine SP6 Kit (Ambion). To generate the transgenic zebrafish, we mixed the expression constructs of pDestTol2CG2-krt4-myrAkt1-IRES-EGFP-pA (50 ng/nL) with transposases mRNA (50 ng/nL). Approximately 1-3 nL DNA of a DNA/ RNA solution was microinjected into the animal pole of one-cell stage embryos. The injected embryos were raised to adulthood. The putative founders were then identified by the green fluorescent signals in the heart of their F1 progenies, which derived from outcrossing with WT. All experiments were approved by the animal use committee at Chung Yuan Christian University (approval ID. 9815). The transgenic fish line nomenclature of Tg(krt4:Hsa.myrAkt1) cy18 was approved by the Zebrafish Nomenclature Committee of ZFIN (http://zfin.org).
Histology
We used a plastic section to analyze the epidermal histology of zebrafish embryo. Zebrafish larvae aged 5 dpf were fixed overnight in 4% paraformaldehyde at 4uC and then dehydrated overnight in 100% methanol at 220uC. After complete dehydration, samples were infiltrated and embedded in Technovit7100 resin (HeraeusKulzer). Samples were sectioned at 1-2 mm intervals and stained with hematoxylin and an eosin staining kit (Merck). To compare the skin thickness and area between WT and transgenic, we took photos at 2006magnification and then selected and processed the region of interesting (ROI) using Photoshop CS3 and Image J software (http://rsbweb.nih.gov/ij/download.html). We used paraffin section to analyze the adipose cell distribution. Adult zebrafish aged 8 months old were first fixed 1 day in 4% PFA and then 3 days in Davidson's solution (30% ethyl alcohol, 10% Acetic acid, 20% formalin, and 30% ddH 2 O) at room temperature. The samples were then dehydrated with ethanol, cleared with Neo-clear (Merck), and embedded in Paraplast Plus (Leica). Samples were sectioned at 5 mm intervals and stained with Periodic acid-Schiff (PAS) (Merck) or Masson's trichrome kit (Merck). To compare the adipocyte cell size and number between WT and transgenics, we took photos at 406 magnification and selected and processed a ROI measuring 650 6 650 mm into 8-bit grey scale using Photoshop CS3. We then calculated the cell size and number using Image J software.
Body Length and Weight Measurement
Mixed gender WT and Tg (krt4:Hsa.myrAkt1) cy18 embryos were raised in 10 L tanks separately until they reached 3 months old (n = 30 for each group). At this point, WT and Tg(krt4:Hsa.myrAkt1) cy18 were again sorted according to their gender and subsequently raised in 30 L tanks (n = 7 for males and n = 15 for female). The standard body length and body weight were measured every month until the fish reached five months old, at which point they were sacrificed for lipid measurement.
Oil Red O Staining
Oil Red O staining was carried out as described by Flynn and colleagues [29] . Zebrafish were fixed in 4% PFA overnight and then washed with PBST for 1 hr at room temperature. After removal from PBST, fish were balanced with 60% isopropanol for 1 hr and immersed in 0.2% Oil Red O in a 60% isopropanol solution overnight and then washed with 60% isopropanol for 1 day.
Nile Red Staining
Nile red staining was carried out as described by Flynn and colleagues [29] . Zebrafish were incubated in 0.25 mg/ml nile red solution in 0.04% acetone in the dark at 28uC for 30 min and then washed with fish water for 1 min to reduce staining background. After anesthetizing with MS222, fish were mounted in 3% methyl cellulose and imaged using a fluorescence dissecting microscope (Nikon SMZ 1500) equipped with a GFP long-pass filter.
Measurement of Total Triglyceride and Cholesterol Contents
Total triglyceride and cholesterol in the whole zebrafish was measured using a commercial assay kit (Diasys Diagnostic Systems) and detected by a Synergy HT Multi-Mode Microplate Reader (BioTek Instruments Inc., Vermont, USA). Both wild type and F1 Tg(krt4:Hsa.myrAkt1) cy18 fish aged 5 months old were sacrificed and completely homogenized into powder in liquid nitrogen. The fish powder was mixed with 5 ml chloroform/methanol (2:1) to extract lipids, and the soluble fraction was filtered into a 15 ml centrifuge tube. After removing a 10ml sample to combine with 10 ml Triton X-100, the excess solvent was evaporated by a vacuum pump at room temperature and weighed to measure total lipid mass per fish. Mass measurements are reported as mean 6 SD.
Immunostaining and Fluorescence Microscopy
Zebrafish larvae aged 3 dpf were fixed in 4% paraformaldehyde for 1 h at 4uC, followed by 16 PBST washing (PBS with 0.1% Triton X-100) for 30 min at 4uC. Larvae were then dehydrated with 100% methanol for at least 1 h and then kept at 220uC. After PBST washing for 30 min at 4uC, larvae were blocked in 3% BSA/PBST for 1 h at 4uC. Rabbit polyclonal antibody against a short amino acid sequence containing human Akt1 (pan-Akt1/ 2/3, sc-8312, Santa Cruz) was diluted to 1:100 in 3% BSA/PBST and incubated with larvae overnight at 4uC. The next day, the larvae were washed 16 PBST for 30 min at 4uC and incubated with a goat anti-rabbit Alexa 488 (Invitrogen) solution diluted to 1:200 in 3% BSA/PBST for 1 h at room temperature. Images were acquired by a fluorescence dissecting microscope (Nikon SMZ 1500) equipped with an Evolution VF monochrome CCD (Media Cybernetics).
Western Blot
Tail fins were collected from 20 individuals of either wild-type or Tg(krt4:Hsa.myrAkt1) cy18 and homogenized in a protein lysis buffer (250 mM sucrose, 20 mM Hepes, 1 mM EDTA, pH7.4, 1% protease inhibitor, Sigma). The lysates were centrifuged at 13,000 rpm for 20 min at 4uC to remove debris, and the supernatant was collected for further analysis. The level of protein concentration was determined by BCA protein assay kit (Thermo) and detected by Synergy HT Multi-Mode Microplate Reader (BioTek Instruments Inc., Vermont, USA). Thirty-five mg of proteins were separated by 12.5% SDS-PAGE and transferred to polyvinylidene difluoride (PVDF) membranes (Millipore). Following incubation with a blocking solution, PVDF membranes were incubated with primary antibodies (1:1000 dilution) overnight and then incubated with HRP-conjugated secondary antibodies (1:3500 dilution) for 1 hr at room temperature. The primary antibodies used were listed as follows: rabbit anti-human Akt1/2/ 3 (sc-8312, Santa Cruz), rabbit anti-human phospho-Akt1/2/3 at Ser 473 position (sc-7985-R, Santa Cruz), rabbit anti-human phospho-GSK3a/b (pY279/pY216) (2309-1, Epitomics), rabbit anti-human p70 S6 kinase alpha (pT421/pS424) (1135-1, Epitomics), rabbit anti-human phospho-mTOR (pS2448) (2971, Epitomics), and mouse anti b-actin (sc-69879, Santa Cruz). After a series of washing, protein bands were detected by incubating in WEST-ZOL PLUS solution (iNtRON Biotechnology, Korea) for 2 min at room temperature in a dark room. Images were acquired using a FUJIFILM LAS 3000 Imaging Analyzer (FUJIFILM, Taiwan).
Real-time RT-PCR
We dissected two tail tissues (as a pooled sample) taken from six month-old WT and Tg(krt4:Hsa.myrAkt1) cy18 (n = 5) and homogenized in Trizol reagent (Ambion). The total RNA was isolated following the manufacturer's instructions. The RNA was treated with DNase I at 25uC for 10 minutes to remove DNA contamination and then cleaned using RNase-free spin columns (Qiagen). The total RNA concentration was determined by spectrophotometry (ND-1000; NanoDropTechnol, Wilmington, DE), and the RNA quality was checked by running electrophoresis in RNA-denatured gels. The total RNA thus extracted was stored at 220uC. For real-time RT-PCR, 1 mg sample of total RNA was reverse-transcribed with reverse transcriptase and then digested with E.coli RNase H to enhance the cDNA purity. Real-time RT-PCR was performed in a Roche LightCycler480 following the manufacturer's instructions. The primer sequence used to perform real-time RT-PCR and their corresponding amplicon size are listed in Table S1 .
Microarray Analysis
The Zebrafish 14 K oligo microarray chip was obtained from the Institute of Cellular and Organismic Biology at Academia Sinica. This chip contained 14,067 oligonucleotides representing 9,666 unique genes with a redundancy of 31%. The detail oligonucleotide description is available from OcimunBiosolutions (http://www.ocimumbio.com/web/default.asp). We used a SuperScript TM Indirect cDNA Labeling System kit (Invitrogen) to generate fluorescently labeled probes. The total RNA isolated from WT and Tg(krt4:Hsa.myrAkt1) cy18 was reversed transcribed into cDNA and coupled for Alexa Fluor 555 and Alexa Fluor 647 fluorescent dyes (Invitrogen), respectively. Before hybridization, the Zebrafish microarray chips were pretreated with 1% bovine serum albumin, 46SCC, and 1% sodium dodecylsulfate (SDS) for 45 min at 42uC, and then hybridized in SlideHyb TM buffer (Ambion) overnight at 42uC. After hybridization, chips were washed with 26 SSC and 0.5% SDS for 15 min at 25uC and then again with 0.56 SSC and 0.5% SDS for 15 min at 25uC. The fluorescence intensities of Alexa Fluor 555 and Alexa Fluor 647 targets were determined using a Genepix scanner (Molecular Devices, Sunnyvale, CA, USA) and the acquired data were analyzed using Genepix and Genespring software (Aglient Technologies, Foster City, CA, USA). The microarray data were submitted to NCBI Gene Expression Omnibus (http://www.ncbi. nlm.nih.gov/geo/) under accession numbers GSM542371 to GSM542373.
Morpholino Oligo Injection
To achieve the maximal knock-down effect, 1 nl of seriallydiluted MOs (purchased from Gene Tools) at concentrations of 1, 0.5, 0.25, and 0.1 mM were injected into yolks at the 1-cell stage. The optimal dosage for gene knockdown was as follows: mTOR splicing block MO, 59-GGTTTGACACATTACCCTGAG-CATG-39 at 5 ng/embryo; 70S6K splicing block MO, 59-CAGTCTTCAACTTACGTGAACAAGA-39 at 5 ng/embryo. Previous research has reported the specificity and efficacy of both MOs [78] .
Swimming Behavior Assay
Zebrafish aged 8 months old were individually incubated in 100 mL of fish water in home-made plastic dishes with a 7 cm diameter. Eight samples were collected from either WT or transgenic groups, and their swimming behavior was recorded with a digital camera for 5 min. Each animal's level of activity was analyzed using video-based animal movement tracking software (EthoVision XT, Noldus).
Elucidation of Genomic Integration Site
Genomic DNA was extracted from tail fin tissues of Tg(krt4:Hsa.myrAkt1) cy18 using a commercial kit (GeneMark, Taiwan) and digested with StuI restriction enzyme. The StuIdigested genomic DNA fragments were ligated with an adapter and then subjected to PCR following the manufacturer's instructions (Genome Walker kit, Clontech). The amplified PCR products were then directly subjected to DNA sequencing and the readouts were performed BLAT search against zebrafish genome database (Zv9 dataset/danRer7) at the UCSC genome browser (http://genome.ucsc.edu/).
Blood Glucose Measurement
Zebrafish were sacrificed by cutting off the tail and the blood samples were collected with a glass capillary measuring 1 mm in diameter. Blood samples of approximately 5 uL were then applied to the sensor chip of a commercial blood glucose meter (AccuChek performa, Roche Diagnostics, detection range = 102600 mg/dl) to measure the blood glucose level at fasting, feeding, or after feeding status. 
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